Press Releases Vivos Inc.

Equities

RDGL

US92858K2042

Market Closed - OTC Markets Other stock markets 03:58:56 2024-06-04 pm EDT			5-day change	1st Jan Change
0.16 ^USD	0.00%		-4.65%	+121.30%

May. 09	Vivos Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
Mar. 18	Vivos Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Radiogel™ Precision Radionuclide Therapy™ Receives FDA Breakthrough Device Designation	Dec. 20	AQ
Vivos : Quarterly Progress Report - Form 8-K	23-10-11	PU
Vivos Inc. Announces Certification of Three New IsoPet® Precision Radionuclide Therapy Regional Clinics	23-08-07	AQ
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	23-05-04	AQ
VIVOS INC : Unregistered Sale of Equity Securities (form 8-K)	23-05-02	AQ
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	23-03-01	AQ
Vivos Inc Files a New Patent on Alternate Particles for Precision Radionuclide Therapy	23-01-11	AQ
Vivos Inc Files a New Patent on Precision Radionuclide Therapy Support System Equipment	23-01-03	AQ
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-10-19	AQ
Vivos Inc Files a New Patent on the Hydrogel Component of IsoPet®/RadioGel™	22-09-14	AQ
Vivos Inc. Announces a New IsoPet® Precision Radionuclide Therapy Regional Clinic for Equine Therapy	22-08-16	AQ
Vivos : Quarterly Report for Quarter Ending June 30, 2022 (Form 10-Q)	22-07-25	PU
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-07-25	AQ
Vivos : Unregistered Sales of Equity Securities - Form 8-K	22-07-11	PU
VIVOS INC : Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	22-07-11	AQ
Vivos Inc. Provides Intellectual Property Protection Update	22-05-12	GL
VIVOS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	22-05-10	AQ
Vivos Inc Implements Multiple Patient IsoPet® Therapy Day	22-04-21	GL
VIVOS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS. (form 10-K)	22-03-07	AQ
Vivos Inc. Enhances its Intellectual Property Protection	22-02-24	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Vivos Inc.

Equities

RDGL

US92858K2042

Press Releases

Filters